1 October، 2026

cells

Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells

DGN Gate 3 June، 2025
WALTHAM, Mass. Minerva Biotechnologies published “Effective CAR T cell targeting of a MUC1 cleavage product” in the...
Read More Read more about Minerva Biotechnologies – Overcoming the Solid Tumor Barrier: MUC1*-Targeted CAR T bearing 1XX mutations overcomes exhaustion and enables killing of low antigen expressing cancer cells
Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE

Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE

DGN Gate 29 March، 2025
Abu Dhabi, 28 March 2025: The Department of Health – Abu Dhabi (DoH) has announced the introduction...
Read More Read more about Department of Health – Abu Dhabi, through Abu Dhabi Stem Cells Center, introduces advanced gene-editing therapy for sickle cell disease and thalassemia for first time in UAE